Xiaogang Pan

Pan Xiaogang, currently Managing Director of AstraZeneca-CICC Fund and Business Development in AstraZeneca China, leads the investment activities in innovative medicine. Xiaogang has nearly 20 years of combined experience in research, business development and investment. Prior to joining AstraZeneca in 2015, Xiaogang worked for Amgen, Bayer, GSK and Ferring. Xiaogang holds a Ph.D. in Pharmaceutics from The Ohio State University.